Tributyltin and dibutyltin alter secretion of tumor necrosis factor alpha from human natural killer cells and a mixture of T cells and natural killer cells

Journal of Applied Toxicology

Volumn 33, Issue 6, 2013, Pages 503-510

  Hurt, Kelsi ^a   Hurd Brown, Tasia ^a   Whalen, Margaret ^a  

^a TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

DBT; NK cells; T cells; TBT; TNF

Indexed keywords

DIBUTYLTIN; TRIBUTYLTIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOMODULATION; IMMUNOTOXICITY; MALE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; T LYMPHOCYTE;

CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; ORGANOTIN COMPOUNDS; T-LYMPHOCYTES; TRIALKYLTIN COMPOUNDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876735312     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2822     Document Type: Article

References (48)

1. Abraha A, Rana, K, Whalen MM. 2010. Role of protein kinase C in the TBT-induced inhibition of lytic function and MAPK activation in human natural killer cells. Arch. Environ. Cont. Toxicol. 59: 661-669.
2. Aluoch A, Whalen MM. 2005. Tributyltin-induced effects on MAP kinases p38 and p44/42 in human natural killer cells. Toxicology 209: 263-277.
3. Aluoch AO, Odman-Ghazi SO, Whalen MM. 2006 Alteration of an essential NK cell signaling pathway by low doses of tributyltin in human natural killer cells. Toxicology 224: 229-237.
4. Aluoch AO, Odman-Ghazi SO, Whalen MM. 2007 Pattern of MAP kinases p44/42 and JNK activation by non-lethal doses of tributyltin in human natural killer cells. Arch. Toxicol. 81: 271-277.
5. Andoniou CE, Coudert JD, Degli-Esposti MA. 2008. Cross talk between NK cells and adaptive immune cells. Killers and beyond: NK-cell-mediated control of immune responses. Eur. J. Immunol. 38: 2927-2968.
6. Ballas ZK, Turner JM, Turner DA, Goetzman EA, Kemp JD. 1990. A patient with simultaneous absence of "classical"- natural killer cells (CD3-, CD16+, and NKH1+) and expansion of CD3+, CD4-, CD8-, NKH1+ subset. J. Allergy Clin. Immunol. 85: 453-459.
7. Biron CA, Byron KS, Sullivan JL. 1989. Severe herpes virus in an adolescent without natural killer cells. New Engl. J. Med. 320: 1731-1735.
8. Black RA, Rauch CT, Kozlosky CJ, Peshcon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP 1997. A metalloproteinase disintegrin that releases tumor necrosis factor-α from cells. Nature 385: 729-733.
9. Catlin R, Shah H, Bankhurst AD, Whalen MM. 2005 Dibutyltin exposure decreases granzyme B and perforin in human natural killer cells. Environ. Toxicol. Pharmacol. 20: 395-403.
10. Chen X, Xun K, Chen L, Wang Y. 2009. TNF-alpha, a potent lipid metabolism regulator. Cell Biochem. Funct. 27: 407-416.
11. Crowe AJ 1987. Organotin compounds in agriculture since 1980. Part 1. Fungicidal, bactericidal and herbicidal properties. Appl. Organomet. Chem. 1: 143-155.
12. Cubero FJ, Nieto N. 2012. Arachidonic acid stimulates TNFα production in Kupffer cells via a reactive oxygen species-pERK1/2-Egr-1-dependent mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 303: G228-239.
13. Dudimah FD, Odman-Ghazi SO, Hatcher F, Whalen MM. 2007a. Effect of Tributyltin (TBT) on the ATP levels in human natural killer cells: Relationship to TBT- induced decreases in NK function. J. Appl. Toxicol. 27: 86-94.
14. Dudimah FD, Gibson C, Whalen MM. 2007b. Effect of Dibutyltin (DBT) on ATP levels in human natural killer cells. Environ. Toxicol. 22: 117-123.
15. Fleisher G, Koven N, Kamiya H, Henle W. 1982. A non-X-linked syndrome with susceptibility to severe Epstein-Bar virus infections. J. Pediatr. 100: 727-730.
16. Fulton A, Heppner G, Roi L, Howard L, Russo J, Brennan M. 1984. Relationship of natural killer cytotoxicity to clinical and biochemical parameters of primary human breast cancer. Breast Cancer Res. Treat. 4: 109-116.
17. Gais P, Tiedje C, Altmayr F, Gaestel M, Weighardt H, Holzmann B. 2010. TRIF signaling stimulates translation of TNF-alpha mRNA via prolonged activation of MK2. J. Immunol. 184: 5842-5848.
18. Ghoneum M, Hussein AE, Gill G, Alfred LJ. 1990. Suppression of murine natural killer cell activity by tributyltin: In vivo and in vitro assessment. Environ. Res. 52: 178-186.
19. Gipperth L. 2009. The legal design of the international and European Union ban on tributyltin antifouling paint: Direct and indirect effects. J. Environ. Manag. 90: S86-S95.
20. Goetz FW, Planas JV, MacKenzie S. 2004. Tumor necrosis factors. Develop. Comp. Immunol. 28: 487-497.
21. Grivennikov SI, Karin M. 2011. Inflammatory cytokines in cancer: tumor necrosis factor and interleukin 6 take the stage. Ann. Rheum. Dis. 70 (Suppl.1): i104-i108.
22. Guicciardi ME, Gores GJ. 2009. Life and death by death receptors. FASEB J. 23: 1625-1637.
23. Hanna N. 1980. Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural-killer cell-mediated cytotoxicity. Int. J. Cancer 26: 675-690.
24. Kannan K, Senthilkumar K, Giesy JP. 1999. Occurrence of butyltin compounds in human blood. Environ. Sci. Technol. 33: 1776-1779.
25. Kannan K, Tanabe S, Tatsukawa R. 1995. Occurrence of butyltin residues in certain foodstuffs. Bull. Environ. Contam. Toxicol. 55: 510-516.
26. Kiessling R., Haller O. 1978. Natural killer cells in the mouse, an alternative surveillance mechanism? Contemp. Topics Immunobiol. 8: 171-201.
27. Lanier L.L. 2008. Up on a tightrope: natural killer cell activation and inhibition. Nature Immunol. 9: 495-502.
28. Lotzova E. 1993. Definition and function of natural killer cells. Nat. Immunol. 12: 177-193.
29. Macarthur M, Hold GL, El-Omar EM. 2004. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal maliganancy. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G515-G520.
30. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR. 2001. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol. Cell. Biol. 21: 6461-6469.
31. Makrigiannis AP, Anderson SK. 2003. Regulation of natural killer cell function. Cancer Biol. Ther. 2: 610-616.
32. Meyer TPH, Zehnter I, Hofmann B, Zaisserer J, Burkhart J, Rapp S, Weinauer F, Schmitz J, Illert WE. 2005. Filter buffy coats (FBC): A source of peripheral blood leukocytes recovered from leukocyte depletion filters. J. Immunol. Methods 307: 150-166.
33. Mishra R, Chen AT, Welsh RM, Szomolanyi-Tsuda E. 2010. NK Cells and γδ T cells mediate resistance to polyomavirus-induced tumors. PLoS Pathog. 6:e10000924.
34. Nakano K, Tsunoda M, Konno N. 2004. Tributyltin (TBT) increases TNFα mRNA expression and induces apoptosis in the murine macrophage cell line in vitro. Environ. Health Prev. Med. 9: 266-271.
35. Odman-Ghazi SO, Hatcher F, Whalen, MM. 2003 Expression of functionally relevant cell surface markers in dibutyltin-exposed human natural killer cells. Chem. Biol. Interact. 146: 1-18.
36. Odman-Ghazi SO, Abraha A, Isom ET, Whalen MM. 2010. Dibutyltin activates MAP kinases in human natural killer cells, in vitro. Cell Biol. Toxicol. 26: 469-479 PMCID: PMC2892640
37. Ortaldo JR, Glenn GM, Young HA, Frey JL. 1992. Natural killer (NK) cell lytic dysfunction and putative NK cell receptor expression abnormality in member of a family with chromosome 3p-linked von Hippel-Lindau disease. J. Natl. Cancer Inst. 84: 1897-1903.
38. Philip R, Epstein LB. 1986. Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferron and interleukin-1. Nature 323: 86-89.
39. Purdy AK, Campbell KS. 2009. Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR). Cancer Biol. Ther. 8: 13-22.
40. Roper WL. 1992. Toxicological Profile for Tin. U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry.
41. Sadiki A-I, Williams DT, Carrier R, Thomas B. 1996. Pilot study on the contamination of drinking water by organotin compounds from PVC materials. Chemosphere 32: 2389-2398.
42. Shurety W, Merino-Trigo A, Brown D, Hume DA, Stow JL. 2000. Localization and post-golgi trafficking of tumor necrosis factor α in macrophages. J. Interferon Cytokine Res. 20: 427-438.
43. Silke J. 2011. The regulation of TNF signaling: what a tangled web we weave. Curr. Opin. Immunol. 23: 620-626.
44. Takahashi S, Mukai H, Tanabe S, Sakayama K, Miyazaki T, Masuno H. 1999. Butyltin residues in the liver of humans and wild terrestrial mammals and in the plastic products. Environ. Pollut. 106: 213-218.
45. Thomas LD, Shah H, Green SA, Bankhurst AD, Whalen MM. 2004. Tributyltin exposure causes decreased granzyme B and perforin levels in human natural killer cells. Toxicology 200: 221-233.
46. Wester PW, Krajnc EI, van Leeuwen FX, Loeber JG, van der Heijden CA, Vaessen HA, Helleman PW. 1990. Chronic toxicity and carcinogenicity of bis(tri-n-butyltin)oxide (TBTO) in the rat. Food Chem. Toxicol. 28: 179-196.
47. Whalen MM, Loganathan BG, Kannan K. 1999. Immunotoxicity of environmentally relevant concentrations of butyltins on human natural killer (NK) cells in vitro. Environ. Res. 81: 108-116.
48. Whalen MM, Ghazi S, Loganathan BG, Hatcher F. 2002. Expression of CD16, CD18 and CD56 in Tributyltin-exposed human natural killer cells. Chemico-Biol. Interact. 139: 159-176.